Cite
HARVARD Citation
Ciaglia, E. et al. (2017). The isoprenoid derivative N6‐benzyladenosine CM223 exerts antitumor effects in glioma patient‐derived primary cells through the mevalonate pathway. British journal of pharmacology. pp. 2287-2301. [Online].